Current Assets Изменить Дата
Acadia Pharmaceuticals USD 499.17M 6.54M 2023-09
Aceragen USD 5.64M 12.23M 2023-03
Agios Pharmaceuticals USD 704.35M 52.89M 2023-09
Alnylam Pharmaceuticals USD 2.99B 461.4M 2023-09
Amgen USD 48.48B 1.1B 2023-09
Biogen USD 8.45B 1.98B 2023-09
BioMarin Pharmaceutical USD 2.96B 5.19M 2023-09
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 15.98B 1.69B 2023-09
Incyte USD 4.4B 138.23M 2023-09
Ionis Pharmaceuticals USD 2.58B 32.1M 2023-09
Lumos Pharma USD 47.45M 8.54M 2023-09
Moderna USD 10.8B 200M 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
PTC Therapeutics USD 540.36M 49.33M 2023-09
Regeneron Pharmaceuticals USD 18.63B 1.71B 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Incyte Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.